Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression ...
Major depressive disorder (MDD) is a severe form of depression characterized by a persistent low mood, hopelessness, disruptions in sleep and/or eating habits, as well as a loss of motivation and ...
Major Depressive Disorder (MDD) is increasingly recognised not solely as an affective disorder but also as one characterised by enduring cognitive impairments. These deficits, affecting domains such ...
USA: Major Depressive Disorder (MDD), a debilitating psychiatric condition affecting millions worldwide, shares a distinct Type 2 helper T-cell (Th2) immune signature with atopic dermatitis (AD), ...
Although there are many potential treatment modalities for MDD, the present article will only address key treatment types that have been empirically supported and are the most relevant to primary care ...
Remission (MADRS total score ≤10) was seen in 65% of patients treated with lumateperone in combination with an oral antidepressant, at 6 months. The Food and Drug Administration (FDA) has approved ...
This study presents valuable findings for identifying biotypes of depression patients using white matter measures, which are under-utilised and under-appreciated in current biological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results